A comprehensive computational analysis to explore the importance of SIGLECs in HCC biology

Abstract Background Hepatocellular carcinoma (HCC) is an aggressive, malignant cancer with a complex pathogenesis. However, effective therapeutic targets and prognostic biomarkers are limited. Sorafenib provides delaying cancer progression and survival improvement in advanced HCC. But despite 10 yea...

Full description

Bibliographic Details
Published in:BMC Gastroenterology
Main Authors: Senbang Yao, Wenjun Chen, Tingting Chen, He Zuo, Ziran Bi, Xiuqing Zhang, Lulian Pang, Yanyan Jing, Xiangxiang Yin, Huaidong Cheng
Format: Article
Language:English
Published: BMC 2023-02-01
Subjects:
Hepatocellular carcinoma
Sorafenib
Prognostic markers
Immunotherapy
Tumour progression
Online Access:https://doi.org/10.1186/s12876-023-02672-z

Internet

https://doi.org/10.1186/s12876-023-02672-z

Similar Items